Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[(3,5-dichloro-4-trioxidanylphenyl)amino]benzoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
A synthetic small molecule with the chemical formula C13H9Cl2NO5 and a molecular weight of approximately 330.12 g/mol. It features a benzoic acid backbone substituted with a dichlorinated phenyl ring bearing a trioxidanyl (hydroxyperoxy) group. The compound is classified as experimental and has not been approved for any therapeutic use or clinical indication to date. No detailed mechanism of action or pharmacological activity has been established in the literature; it is primarily referenced in chemical and drug databases as an experimental entity[1][3][4].
- Other names
- 2-[3,5-dichloro-4-(hydroxyperoxy)phenyl]amino]benzoic acid2-{[3,5-dichloro-4-(hydroxyperoxy)phenyl]amino}benzoic acid2-[3,5-DICHLORO-4-(2-{2-[2(2-MERCAPTOETHOXY)ETHOXY]ETHOXY}ETHOXY)PHENYLAMINO]BENZOIC ACID
02
Targets
TTR (Transthyretin)
Beyond the preview
Go deeper on 2-[(3,5-dichloro-4-trioxidanylphenyl)amino]benzoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-[(3,5-dichloro-4-trioxidanylphenyl)amino]benzoic acid.